Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mullen

Showing results (361-370 of 371) with videos related to

Pageof 38
Sort By:
Gynecologic Oncology|February 22, 2025
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort studyPaulina J Haight, Marilyn Sanchez, Samantha M Thomas, et al.
Photobiomodulation, Photomedicine, and Laser Surgery|June 7, 2024
The Effect of Intranasal Plus Transcranial Photobiomodulation on Neuromuscular Control in Individuals with Repetitive Head Acceleration EventsPaula K Johnson, Peter C Fino, Elisabeth A Wilde, et al.
The Journal of Clinical Investigation|May 20, 2025
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancerAngela Schab, Amanda Compadre, Rebecca Drexler, et al.
Molecular Cancer Research : MCR|August 1, 2023
Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix ProteinsAngela M Schab, Molly M Greenwade, Elizabeth Stock, et al.
Circulation|February 23, 2011
Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative)M Z Khawaja, R Rajani, A Cook, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 27, 2025
Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort studyAngeles Alvarez Secord, Victoria Bae-Jump, Floor Backes, et al.
Animal Reproduction Science|June 29, 2005
Investigation of the Booroola (FecB) and Inverdale (FecX(I)) mutations in 21 prolific breeds and strains of sheep sampled in 13 countriesG H Davis, L Balakrishnan, I K Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2023
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian CancerAmanda J Compadre, Lillian N van Biljon, Mark C Valentine, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2006
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseasesChristine Beeton, Heike Wulff, Nathan E Standifer, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanismsElena Lomonosova, Megan Loeb, Kevin Rodriguez, et al.
Pageof 38

Showing results (361-370 of 371) with videos related to

Sort By:
Pageof 38
Gynecologic Oncology|February 22, 2025
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort studyPaulina J Haight, Marilyn Sanchez, Samantha M Thomas, et al.
Photobiomodulation, Photomedicine, and Laser Surgery|June 7, 2024
The Effect of Intranasal Plus Transcranial Photobiomodulation on Neuromuscular Control in Individuals with Repetitive Head Acceleration EventsPaula K Johnson, Peter C Fino, Elisabeth A Wilde, et al.
The Journal of Clinical Investigation|May 20, 2025
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancerAngela Schab, Amanda Compadre, Rebecca Drexler, et al.
Molecular Cancer Research : MCR|August 1, 2023
Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix ProteinsAngela M Schab, Molly M Greenwade, Elizabeth Stock, et al.
Circulation|February 23, 2011
Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative)M Z Khawaja, R Rajani, A Cook, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 27, 2025
Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort studyAngeles Alvarez Secord, Victoria Bae-Jump, Floor Backes, et al.
Animal Reproduction Science|June 29, 2005
Investigation of the Booroola (FecB) and Inverdale (FecX(I)) mutations in 21 prolific breeds and strains of sheep sampled in 13 countriesG H Davis, L Balakrishnan, I K Ross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2023
RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian CancerAmanda J Compadre, Lillian N van Biljon, Mark C Valentine, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2006
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseasesChristine Beeton, Heike Wulff, Nathan E Standifer, et al.
Biorxiv : the Preprint Server for Biology|August 13, 2025
Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanismsElena Lomonosova, Megan Loeb, Kevin Rodriguez, et al.
Pageof 38